TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10223421
log Bayes Factor = 106.956
Chromosome 6   position 31,390,055  (GRCh37) Explore rs10223421 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
M45.X9 Ankylosing spondylitis (Site unspecified)
1.000 0.000 0.000
L40 Psoriasis
1.000 0.000 0.000
M07.3 Other psoriatic arthropathies
1.000 0.000 0.000
M07.30 Other psoriatic arthropathies (Multiple sites)
1.000 0.000 0.000
M45 Ankylosing spondylitis
1.000 0.000 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.999 0.001 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.999 0.001 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.996 0.004 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.994 0.006 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.993 0.007 0.000
T43.2 Other and unspecified antidepressants
0.990 0.010 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.984 0.016 0.000
L40.0 Psoriasis vulgaris
0.977 0.023 0.000
J45.9 Asthma, unspecified
0.000 0.027 0.973
T39.1 4-Aminophenol derivatives
0.966 0.034 0.000
M45.X2 Ankylosing spondylitis (Cervical region)
0.955 0.045 0.000
T42.4 Benzodiazepines
0.953 0.047 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.952 0.048 0.000
J45 Asthma
0.000 0.058 0.942
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.938 0.062 0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.935 0.065 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.929 0.071 0.000
J45.0 Predominantly allergic asthma
0.000 0.085 0.915
M07.34 Other psoriatic arthropathies (Hand)
0.884 0.116 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.878 0.122 0.000
S01 Open wound of head
0.000 0.127 0.873
S00-S09 Injuries to the head
0.000 0.129 0.871
S02 Fracture of skull and facial bones
0.000 0.135 0.865
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.855 0.145 0.000
S01.3 Open wound of ear
0.000 0.153 0.847
S00 Superficial injury of head
0.000 0.155 0.845
M45.X6 Ankylosing spondylitis (Lumbar region)
0.836 0.164 0.000
S01.8 Open wound of other parts of head
0.000 0.165 0.835
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.834 0.166 0.000
L40.1 Generalised pustular psoriasis
0.827 0.173 0.000
S02.4 Fracture of malar and maxillary bones
0.000 0.173 0.827
L40.4 Guttate psoriasis
0.826 0.174 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.822 0.178 0.000
K90 Intestinal malabsorption
0.000 0.185 0.815
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.815 0.185 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.814 0.186 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.812 0.188 0.000
S01.1 Open wound of eyelid and periocular area
0.000 0.188 0.812
S02.8 Fractures of other skull and facial bones
0.000 0.191 0.809
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.808 0.192 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.807 0.193 0.000
T38.1 Thyroid hormones and substitutes
0.806 0.194 0.000
S00.1 Contusion of eyelid and periocular area
0.000 0.200 0.800
S02.40 Fracture of malar and maxillary bones (closed)
0.000 0.201 0.799
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.798 0.202 0.000
L40.8 Other psoriasis
0.795 0.205 0.000
S06 Intracranial injury
0.000 0.207 0.793
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.791 0.209 0.000
M07.31 Other psoriatic arthropathies (Shoulder region)
0.789 0.211 0.000
T42.0 Hydantoin derivatives
0.788 0.212 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.776 0.223 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.771 0.229 0.000
S00.3 Superficial injury of nose
0.000 0.230 0.770
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.769 0.231 0.000
S02.80 Fractures of other skull and facial bones (closed)
0.000 0.232 0.768
S02.6 Fracture of mandible
0.000 0.235 0.765
S00.2 Other superficial injuries of eyelid and periocular area
0.000 0.244 0.756
S01.7 Multiple open wounds of head
0.000 0.244 0.756
T50.8 Diagnostic agents
0.741 0.259 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.259 0.741
S01.4 Open wound of cheek and temporomandibular area
0.000 0.265 0.735
J33.0 Polyp of nasal cavity
0.000 0.267 0.733
J33 Nasal polyp
0.000 0.273 0.727
T42.1 Iminostilbenes
0.726 0.274 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.726 0.274 0.000
J40-J47 Chronic lower respiratory diseases
0.000 0.278 0.722
T38.8 Other and unspecified hormones and their synthetic substitutes
0.720 0.280 0.000
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
M07.38 Other psoriatic arthropathies (Other)
0.717 0.283 0.000
M07.33 Other psoriatic arthropathies (Forearm)
0.717 0.283 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.717 0.283 0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)
0.717 0.283 0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.717 0.283 0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)
0.717 0.283 0.000
M45.X4 Ankylosing spondylitis (Thoracic region)
0.717 0.283 0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)
0.717 0.283 0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)
0.717 0.283 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.714 0.286 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.714 0.286 0.000
T43.9 Psychotropic drug, unspecified
0.712 0.288 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.712 0.288 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.712 0.288 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.712 0.288 0.000
T42.3 Barbiturates
0.712 0.288 0.000
T42.2 Succinimides and oxazolidinediones
0.712 0.288 0.000
Chapter X Diseases of the respiratory system
0.000 0.291 0.709
T43.6 Psychostimulants with abuse potential
0.708 0.292 0.000
T39.4 Antirheumatics, not elsewhere classified
0.706 0.294 0.000
T39.2 Pyrazolone derivatives
0.706 0.294 0.000
J84 Other interstitial pulmonary diseases
0.000 0.295 0.705
J80-J84 Other respiratory diseases principally affecting the interstitium
0.000 0.295 0.705
T46 Poisoning by agents primarily affecting the cardiovascular system
0.700 0.300 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.698 0.302 0.000
K90.8 Other intestinal malabsorption
0.000 0.304 0.696
J30-J39 Other diseases of upper respiratory tract
0.000 0.304 0.696
S00.7 Multiple superficial injuries of head
0.000 0.305 0.695
S02.60 Fracture of mandible (closed)
0.000 0.307 0.693
S01.5 Open wound of lip and oral cavity
0.000 0.311 0.689
S06.2 Diffuse brain injury
0.000 0.311 0.689
J84.1 Other interstitial pulmonary diseases with fibrosis
0.000 0.313 0.687
S06.3 Focal brain injury
0.000 0.316 0.684
S02.9 Fracture of skull and facial bones, part unspecified
0.000 0.317 0.683
J30 Vasomotor and allergic rhinitis
0.000 0.319 0.681
S02.2 Fracture of nasal bones
0.000 0.320 0.680
T50.6 Antidotes and chelating agents, not elsewhere classified
0.678 0.322 0.000
S00.5 Superficial injury of lip and oral cavity
0.000 0.324 0.676
J33.9 Nasal polyp, unspecified
0.000 0.324 0.676
J45.8 Mixed asthma
0.000 0.324 0.675
J45.1 Nonallergic asthma
0.000 0.324 0.675
T36 Poisoning by systemic antibiotics
0.675 0.325 0.000
J30.1 Allergic rhinitis due to pollen
0.000 0.325 0.675
T50.7 Analeptics and opioid receptor antagonists
0.673 0.327 0.000
T50.5 Appetite depressants
0.673 0.327 0.000
T50.4 Drugs affecting uric acid metabolism
0.673 0.327 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.673 0.327 0.000
T50.1 Loop [high-ceiling] diuretics
0.673 0.327 0.000
T50.0 Mineralocorticoids and their antagonists
0.673 0.327 0.000
J84.9 Interstitial pulmonary disease, unspecified
0.000 0.330 0.670
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.669 0.331 0.000
T38.9 Other and unspecified hormone antagonists
0.666 0.334 0.000
T38.7 Androgens and anabolic congeners
0.666 0.334 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.666 0.334 0.000
T38.5 Other oestrogens and progestogens
0.666 0.334 0.000
T38.4 Oral contraceptives
0.666 0.334 0.000
T38.2 Antithyroid drugs
0.666 0.334 0.000
T38.0 Glucocorticoids and synthetic analogues
0.666 0.334 0.000
S02.7 Multiple fractures involving skull and facial bones
0.000 0.342 0.658
T39.0 Salicylates
0.651 0.349 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.644 0.356 0.000
J95-J99 Other diseases of the respiratory system
0.000 0.356 0.644
S06.6 Traumatic subarachnoid haemorrhage
0.000 0.361 0.639
J99 Respiratory disorders in diseases classified elsewhere
0.000 0.368 0.632
J99.8 Respiratory disorders in other diseases classified elsewhere
0.000 0.373 0.627
S08 Traumatic amputation of part of head
0.000 0.376 0.624
S07 Crushing injury of head
0.000 0.376 0.624
S04 Injury of cranial nerves
0.000 0.376 0.624
S00.0 Superficial injury of scalp
0.000 0.376 0.624
S03 Dislocation, sprain and strain of joints and ligaments of head
0.000 0.381 0.619
S06.9 Intracranial injury, unspecified
0.000 0.383 0.617
S06.20 Diffuse brain injury (without open intracranial wound)
0.000 0.386 0.614
S06.30 Focal brain injury (without open intracranial wound)
0.000 0.395 0.605
J46 Status asthmaticus
0.000 0.398 0.602
S02.41 Fracture of malar and maxillary bones (open)
0.000 0.407 0.593
S01.2 Open wound of nose
0.000 0.413 0.586
S02.0 Fracture of vault of skull
0.000 0.414 0.586
T47.0 Histamine H(2)-receptor antagonists
0.586 0.414 0.000
K90.3 Pancreatic steatorrhoea
0.000 0.416 0.584
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.416 0.584
K90.1 Tropical sprue
0.000 0.416 0.584
L40-L45 Papulosquamous disorders
0.583 0.417 0.000
S02.81 Fractures of other skull and facial bones (open)
0.000 0.420 0.580
S02.5 Fracture of tooth
0.000 0.422 0.578
T47.1 Other antacids and anti-gastric-secretion drugs
0.576 0.424 0.000
T46.1 Calcium-channel blockers
0.575 0.425 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.428 0.572
J33.8 Other polyp of sinus
0.000 0.431 0.569
S06.7 Intracranial injury with prolonged coma
0.000 0.431 0.569
S06.1 Traumatic cerebral oedema
0.000 0.431 0.569
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.567 0.433 0.000
T48.5 Anti-common-cold drugs
0.567 0.433 0.000
T48.4 Expectorants
0.567 0.433 0.000
T48.3 Antitussives
0.567 0.433 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.567 0.433 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.567 0.433 0.000
T48.0 Oxytocic drugs
0.567 0.433 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.567 0.433 0.000
S06.4 Epidural haemorrhage
0.000 0.433 0.567
J84.8 Other specified interstitial pulmonary diseases
0.000 0.433 0.567
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.000 0.435 0.565
M07 Psoriatic and enteropathic arthropathies
0.563 0.437 0.000
S02.20 Fracture of nasal bones (closed)
0.000 0.440 0.560
S06.5 Traumatic subdural haemorrhage
0.000 0.444 0.556
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.555 0.445 0.000
J30.3 Other allergic rhinitis
0.000 0.445 0.555
S00.4 Superficial injury of ear
0.000 0.447 0.553
S02.90 Fracture of skull and facial bones, part unspecified (closed)
0.000 0.447 0.553
S02.1 Fracture of base of skull
0.000 0.448 0.552
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.551 0.448 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.551 0.448 0.000
T47.7 Emetics
0.551 0.448 0.000
T47.6 Antidiarrhoeal drugs
0.551 0.448 0.000
T47.5 Digestants
0.551 0.448 0.000
T47.4 Other laxatives
0.551 0.448 0.000
T47.3 Saline and osmotic laxatives
0.551 0.448 0.000
T47.2 Stimulant laxatives
0.551 0.448 0.000
J33.1 Polypoid sinus degeneration
0.000 0.451 0.549
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.548 0.451 0.000
S02.61 Fracture of mandible (open)
0.000 0.451 0.548
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.546 0.454 0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)
0.000 0.472 0.528
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.520 0.479 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.520 0.479 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.520 0.479 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.520 0.479 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.520 0.479 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.520 0.479 0.000
T44.0 Anticholinesterase agents
0.520 0.479 0.000
S06.8 Other intracranial injuries
0.000 0.485 0.515
J41 Simple and mucopurulent chronic bronchitis
0.000 0.486 0.514
J80 Adult respiratory distress syndrome
0.000 0.487 0.513
T41.5 Therapeutic gases
0.512 0.488 0.000
T41.4 Anaesthetic, unspecified
0.512 0.488 0.000
T41.3 Local anaesthetics
0.512 0.488 0.000
T41.2 Other and unspecified general anaesthetics
0.512 0.488 0.000
T41.1 Intravenous anaesthetics
0.512 0.488 0.000
T41.0 Inhaled anaesthetics
0.512 0.488 0.000
T49.9 Topical agent, unspecified
0.512 0.488 0.000
T49.8 Other topical agents
0.512 0.488 0.000
T49.7 Dental drugs, topically applied
0.512 0.488 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.512 0.488 0.000
T49.5 Ophthalmological drugs and preparations
0.512 0.488 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.512 0.488 0.000
T49.3 Emollients, demulcents and protectants
0.512 0.488 0.000
T49.2 Local astringents and local detergents
0.512 0.488 0.000
T49.1 Antipruritics
0.512 0.488 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.512 0.488 0.000
S02.70 Multiple fractures involving skull and facial bones (closed)
0.000 0.491 0.509
J84.0 Alveolar and parietoalveolar conditions
0.000 0.494 0.506
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.502 0.498 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.502 0.498 0.000
T46.7 Peripheral vasodilators
0.502 0.498 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.502 0.498 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.502 0.498 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.500 0.499 0.000
T37.5 Antiviral drugs
0.500 0.499 0.000
T37.4 Anthelminthics
0.500 0.499 0.000
T37.3 Other antiprotozoal drugs
0.500 0.499 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.500 0.499 0.000
T37.1 Antimycobacterial drugs
0.500 0.499 0.000
T37.0 Sulphonamides
0.500 0.499 0.000
L42 Pityriasis rosea
0.497 0.503 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.496 0.503 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.496 0.504 0.000
S06.21 Diffuse brain injury (with open intracranial wound)
0.000 0.506 0.494
S06.90 Intracranial injury, unspecified (without open intracranial wound)
0.000 0.509 0.491
S06.31 Focal brain injury (with open intracranial wound)
0.000 0.510 0.490
S02.91 Fracture of skull and facial bones, part unspecified (open)
0.000 0.510 0.490
J36 Peritonsillar abscess
0.000 0.511 0.489
J30.0 Vasomotor rhinitis
0.000 0.512 0.488
J82 Pulmonary eosinophilia, not elsewhere classified
0.000 0.513 0.487
T36.9 Systemic antibiotic, unspecified
0.484 0.516 0.000
T36.8 Other systemic antibiotics
0.484 0.516 0.000
T36.7 Antifungal antibiotics, systemically used
0.484 0.516 0.000
T36.6 Rifamycins
0.484 0.516 0.000
T36.5 Aminoglycosides
0.484 0.516 0.000
T36.4 Tetracyclines
0.484 0.516 0.000
T36.3 Macrolides
0.484 0.516 0.000
T36.2 Chloramphenicol group
0.484 0.516 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.484 0.516 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.484 0.516 0.000
S05 Injury of eye and orbit
0.000 0.520 0.480
S02.3 Fracture of orbital floor
0.000 0.526 0.474
S02.71 Multiple fractures involving skull and facial bones (open)
0.000 0.528 0.472
S02.21 Fracture of nasal bones (open)
0.000 0.531 0.469
T46.5 Other antihypertensive drugs, not elsewhere classified
0.466 0.534 0.000
J96 Respiratory failure, not elsewhere classified
0.000 0.538 0.462
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)
0.000 0.542 0.458
J37 Chronic laryngitis and laryngotracheitis
0.000 0.548 0.451
J81 Pulmonary oedema
0.000 0.550 0.450
S06.0 Concussion
0.000 0.551 0.448
S04.9 Injury of unspecified cranial nerve
0.000 0.552 0.447
S04.8 Injury of other cranial nerves
0.000 0.552 0.447
S04.7 Injury of accessory nerve
0.000 0.552 0.447
S04.6 Injury of acoustic nerve
0.000 0.552 0.447
S04.5 Injury of facial nerve
0.000 0.552 0.447
S04.4 Injury of abducent nerve
0.000 0.552 0.447
S04.3 Injury of trigeminal nerve
0.000 0.552 0.447
S04.2 Injury of trochlear nerve
0.000 0.552 0.447
S04.1 Injury of oculomotor nerve
0.000 0.552 0.447
S04.0 Injury of optic nerve and pathways
0.000 0.552 0.447
S07.9 Crushing injury of head, part unspecified
0.000 0.552 0.447
S07.8 Crushing injury of other parts of head
0.000 0.552 0.447
S07.1 Crushing injury of skull
0.000 0.552 0.447
S07.0 Crushing injury of face
0.000 0.552 0.447
S08.9 Traumatic amputation of unspecified part of head
0.000 0.552 0.447
S08.8 Traumatic amputation of other parts of head
0.000 0.552 0.447
S08.1 Traumatic amputation of ear
0.000 0.552 0.447
S08.0 Avulsion of scalp
0.000 0.552 0.447
T36.0 Penicillins
0.444 0.555 0.000
S03.5 Sprain and strain of joints and ligaments of other and unspecified parts of head
0.000 0.556 0.444
S03.4 Sprain and strain of jaw
0.000 0.556 0.444
S03.3 Dislocation of other and unspecified parts of head
0.000 0.556 0.444
S03.1 Dislocation of septal cartilage of nose
0.000 0.556 0.444
S03.0 Dislocation of jaw
0.000 0.556 0.444
S06.91 Intracranial injury, unspecified (with open intracranial wound)
0.000 0.557 0.443
S03.2 Dislocation of tooth
0.000 0.561 0.439
J85 Abscess of lung and mediastinum
0.000 0.563 0.437
J86 Pyothorax
0.000 0.564 0.436
J30.2 Other seasonal allergic rhinitis
0.000 0.567 0.433
T46.4 Angiotensin-converting-enzyme inhibitors
0.433 0.567 0.000
T45.0 Antiallergic and antiemetic drugs
0.430 0.570 0.000
J90-J94 Other diseases of pleura
0.000 0.572 0.428
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.423 0.576 0.000
J99.1 Respiratory disorders in other diffuse connective tissue disorders
0.000 0.579 0.421
L43 Lichen planus
0.421 0.579 0.000
S02.01 Fracture of vault of skull (open)
0.000 0.580 0.420
L44 Other papulosquamous disorders
0.418 0.582 0.000
L41 Parapsoriasis
0.418 0.582 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.418 0.582 0.000
J47 Bronchiectasis
0.000 0.582 0.418
T40.1 Heroin
0.416 0.584 0.000
S02.51 Fracture of tooth (open)
0.000 0.586 0.414
J43 Emphysema
0.000 0.587 0.413
S06.11 Traumatic cerebral oedema (with open intracranial wound)
0.000 0.592 0.408
S06.10 Traumatic cerebral oedema (without open intracranial wound)
0.000 0.592 0.408
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)
0.000 0.592 0.408
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)
0.000 0.592 0.408
S06.41 Epidural haemorrhage (with open intracranial wound)
0.000 0.594 0.406
J00-J06 Acute upper respiratory infections
0.000 0.594 0.406
J99.0 Rheumatoid lung disease
0.000 0.594 0.406
S06.40 Epidural haemorrhage (without open intracranial wound)
0.000 0.596 0.404
M07.6 Other enteropathic arthropathies
0.404 0.596 0.000
M07.5 Arthropathy in ulcerative colitis
0.404 0.596 0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.404 0.596 0.000
M07.2 Psoriatic spondylitis
0.404 0.596 0.000
M07.1 Arthritis mutilans
0.404 0.596 0.000
M07.0 Distal interphalangeal psoriatic arthropathy
0.404 0.596 0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)
0.000 0.601 0.399
S01.9 Open wound of head, part unspecified
0.000 0.602 0.398
J44 Other chronic obstructive pulmonary disease
0.000 0.606 0.394
T45.9 Primarily systemic and haematological agent, unspecified
0.393 0.606 0.000
T45.8 Other primarily systemic and haematological agents
0.393 0.606 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.393 0.606 0.000
T45.6 Fibrinolysis-affecting drugs
0.393 0.606 0.000
T45.4 Iron and its compounds
0.393 0.606 0.000
T45.3 Enzymes, not elsewhere classified
0.393 0.606 0.000
J93 Pneumothorax
0.000 0.607 0.393
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.391 0.608 0.000
T40.8 Lysergide [LSD]
0.391 0.608 0.000
T40.7 Cannabis (derivatives)
0.391 0.608 0.000
T40.5 Cocaine
0.391 0.608 0.000
T40.3 Methadone
0.391 0.608 0.000
T40.0 Opium
0.391 0.608 0.000
T45.2 Vitamins, not elsewhere classified
0.391 0.608 0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)
0.000 0.613 0.387
S02.00 Fracture of vault of skull (closed)
0.000 0.614 0.386
J86.0 Pyothorax with fistula
0.000 0.614 0.386
J03 Acute tonsillitis
0.000 0.615 0.385
J98 Other respiratory disorders
0.000 0.615 0.385
S02.11 Fracture of base of skull (open)
0.000 0.624 0.375
S02.50 Fracture of tooth (closed)
0.000 0.628 0.372
J03.9 Acute tonsillitis, unspecified
0.000 0.629 0.371
S06.81 Other intracranial injuries (with open intracranial wound)
0.000 0.630 0.369
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.000 0.631 0.368
J41.1 Mucopurulent chronic bronchitis
0.000 0.631 0.368
J41.0 Simple chronic bronchitis
0.000 0.635 0.365
J91 Pleural effusion in conditions classified elsewhere
0.000 0.638 0.362
N47 Redundant prepuce, phimosis and paraphimosis
0.000 0.638 0.362
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body
0.000 0.639 0.361
T40.6 Other and unspecified narcotics
0.358 0.642 0.000
S05.9 Injury of eye and orbit, part unspecified
0.000 0.642 0.358
J93.9 Pneumothorax, unspecified
0.000 0.646 0.354
S02.10 Fracture of base of skull (closed)
0.000 0.646 0.354
J44.8 Other specified chronic obstructive pulmonary disease
0.000 0.647 0.353
J85.1 Abscess of lung with pneumonia
0.000 0.655 0.345
S05.7 Avulsion of eye
0.000 0.656 0.344
S05.6 Penetrating wound of eyeball without foreign body
0.000 0.656 0.344
S05.4 Penetrating wound of orbit with or without foreign body
0.000 0.656 0.344
S05.5 Penetrating wound of eyeball with foreign body
0.000 0.657 0.343
S02.31 Fracture of orbital floor (open)
0.000 0.660 0.340
L43.8 Other lichen planus
0.340 0.660 0.000
J39 Other diseases of upper respiratory tract
0.000 0.661 0.339
S05.8 Other injuries of eye and orbit
0.000 0.662 0.338
J98.6 Disorders of diaphragm
0.000 0.664 0.336
J30.4 Allergic rhinitis, unspecified
0.000 0.664 0.336
J98.0 Diseases of bronchus, not elsewhere classified
0.000 0.664 0.336
J85.2 Abscess of lung without pneumonia
0.000 0.665 0.335
J96.9 Respiratory failure, unspecified
0.000 0.669 0.331
J96.1 Chronic respiratory failure
0.000 0.669 0.331
J96.0 Acute respiratory failure
0.000 0.669 0.331
T40.4 Other synthetic narcotics
0.331 0.669 0.000
J20-J22 Other acute lower respiratory infections
0.000 0.676 0.324
J37.1 Chronic laryngotracheitis
0.000 0.676 0.324
T43.0 Tricyclic and tetracyclic antidepressants
0.324 0.676 0.000
S06.01 Concussion (with open intracranial wound)
0.000 0.678 0.322
S05.3 Ocular laceration without prolapse or loss of intraocular tissue
0.000 0.679 0.321
T40.2 Other opioids
0.319 0.681 0.000
J93.1 Other spontaneous pneumothorax
0.000 0.681 0.319
S06.80 Other intracranial injuries (without open intracranial wound)
0.000 0.684 0.316
J43.2 Centrilobular emphysema
0.000 0.684 0.316
J85.3 Abscess of mediastinum
0.000 0.686 0.314
J42 Unspecified chronic bronchitis
0.000 0.688 0.312
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue
0.000 0.698 0.302
L43.3 Subacute (active) lichen planus
0.302 0.698 0.000
L43.2 Lichenoid drug reaction
0.302 0.698 0.000
L43.1 Bullous lichen planus
0.302 0.698 0.000
L43.0 Hypertrophic lichen planus
0.302 0.698 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.301 0.699 0.001
L41.9 Parapsoriasis, unspecified
0.300 0.700 0.000
L41.8 Other parapsoriasis
0.300 0.700 0.000
L41.5 Retiform parapsoriasis
0.300 0.700 0.000
L41.4 Large plaque parapsoriasis
0.300 0.700 0.000
L41.3 Small plaque parapsoriasis
0.300 0.700 0.000
L41.2 Lymphomatoid papulosis
0.300 0.700 0.000
L41.1 Pityriasis lichenoides chronica
0.300 0.700 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.300 0.700 0.000
L44.9 Papulosquamous disorder, unspecified
0.300 0.700 0.000
L44.8 Other specified papulosquamous disorders
0.300 0.700 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.300 0.700 0.000
L44.3 Lichen ruber moniliformis
0.300 0.700 0.000
L44.2 Lichen striatus
0.300 0.700 0.000
L44.1 Lichen nitidus
0.300 0.700 0.000
L44.0 Pityriasis rubra pilaris
0.300 0.700 0.000
J43.1 Panlobular emphysema
0.000 0.704 0.296
J43.0 MacLeod's syndrome
0.000 0.704 0.296
J98.8 Other specified respiratory disorders
0.000 0.705 0.295
J43.8 Other emphysema
0.000 0.707 0.293
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)
0.290 0.710 0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other
0.290 0.710 0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)
0.290 0.710 0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg
0.290 0.710 0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh
0.290 0.710 0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)
0.290 0.710 0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm
0.290 0.710 0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm
0.290 0.710 0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region
0.290 0.710 0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)
0.290 0.710 0.000
M07.19 Arthritis mutilans (Site unspecified)
0.290 0.710 0.000
M07.18 Arthritis mutilans (Other)
0.290 0.710 0.000
M07.17 Arthritis mutilans (Ankle and foot)
0.290 0.710 0.000
M07.16 Arthritis mutilans (Lower leg)
0.290 0.710 0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)
0.290 0.710 0.000
M07.14 Arthritis mutilans (Hand)
0.290 0.710 0.000
M07.13 Arthritis mutilans (Forearm)
0.290 0.710 0.000
M07.12 Arthritis mutilans (Upper arm)
0.290 0.710 0.000
M07.11 Arthritis mutilans (Shoulder region)
0.290 0.710 0.000
M07.10 Arthritis mutilans (Multiple sites)
0.290 0.710 0.000
M07.29 Psoriatic spondylitis (Site unspecified)
0.290 0.710 0.000
M07.28 Psoriatic spondylitis (Other)
0.290 0.710 0.000
M07.27 Psoriatic spondylitis (Ankle and foot)
0.290 0.710 0.000
M07.26 Psoriatic spondylitis (Lower leg)
0.290 0.710 0.000
M07.25 Psoriatic spondylitis (Pelvic region and thigh)
0.290 0.710 0.000
M07.24 Psoriatic spondylitis (Hand)
0.290 0.710 0.000
M07.23 Psoriatic spondylitis (Forearm)
0.290 0.710 0.000
M07.22 Psoriatic spondylitis (Upper arm)
0.290 0.710 0.000
M07.21 Psoriatic spondylitis (Shoulder region)
0.290 0.710 0.000
M07.20 Psoriatic spondylitis (Multiple sites)
0.290 0.710 0.000
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)
0.290 0.710 0.000
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)
0.290 0.710 0.000
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)
0.290 0.710 0.000
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)
0.290 0.710 0.000
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)
0.290 0.710 0.000
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)
0.290 0.710 0.000
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)
0.290 0.710 0.000
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)
0.290 0.710 0.000
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)
0.290 0.710 0.000
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)
0.290 0.710 0.000
M07.59 Arthropathy in ulcerative colitis (Site unspecified)
0.290 0.710 0.000
M07.58 Arthropathy in ulcerative colitis (Other)
0.290 0.710 0.000
M07.57 Arthropathy in ulcerative colitis (Ankle and foot)
0.290 0.710 0.000
M07.56 Arthropathy in ulcerative colitis (Lower leg)
0.290 0.710 0.000
M07.55 Arthropathy in ulcerative colitis (Pelvic region and thigh)
0.290 0.710 0.000
M07.54 Arthropathy in ulcerative colitis (Hand)
0.290 0.710 0.000
M07.53 Arthropathy in ulcerative colitis (Forearm)
0.290 0.710 0.000
M07.52 Arthropathy in ulcerative colitis (Upper arm)
0.290 0.710 0.000
M07.51 Arthropathy in ulcerative colitis (Shoulder region)
0.290 0.710 0.000
M07.50 Arthropathy in ulcerative colitis (Multiple sites)
0.290 0.710 0.000
M07.69 Other enteropathic arthropathies (Site unspecified)
0.290 0.710 0.000
M07.68 Other enteropathic arthropathies (Other)
0.290 0.710 0.000
M07.67 Other enteropathic arthropathies (Ankle and foot)
0.290 0.710 0.000
M07.66 Other enteropathic arthropathies (Lower leg)
0.290 0.710 0.000
M07.65 Other enteropathic arthropathies (Pelvic region and thigh)
0.290 0.710 0.000
M07.64 Other enteropathic arthropathies (Hand)
0.290 0.710 0.000
M07.63 Other enteropathic arthropathies (Forearm)
0.290 0.710 0.000
M07.62 Other enteropathic arthropathies (Upper arm)
0.290 0.710 0.000
M07.61 Other enteropathic arthropathies (Shoulder region)
0.290 0.710 0.000
M07.60 Other enteropathic arthropathies (Multiple sites)
0.290 0.710 0.000
J93.0 Spontaneous tension pneumothorax
0.000 0.710 0.290
J85.0 Gangrene and necrosis of lung
0.000 0.711 0.289
T45.5 Anticoagulants
0.288 0.711 0.001
M45-M49 Spondylopathies
0.287 0.713 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.000 0.715 0.285
S09 Other and unspecified injuries of head
0.000 0.716 0.284
J05 Acute obstructive laryngitis [croup] and epiglottitis
0.000 0.718 0.282
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.000 0.718 0.282
J37.0 Chronic laryngitis
0.000 0.724 0.276
J03.8 Acute tonsillitis due to other specified organisms
0.000 0.724 0.276
J03.0 Streptococcal tonsillitis
0.000 0.724 0.276
J98.3 Compensatory emphysema
0.000 0.724 0.276
J98.2 Interstitial emphysema
0.000 0.725 0.275
J93.8 Other pneumothorax
0.000 0.726 0.274
J60-J70 Lung diseases due to external agents
0.000 0.726 0.273
J02 Acute pharyngitis
0.000 0.732 0.268
J04 Acute laryngitis and tracheitis
0.000 0.736 0.264
S01.0 Open wound of scalp
0.000 0.739 0.261
J35 Chronic diseases of tonsils and adenoids
0.000 0.739 0.261
S05.1 Contusion of eyeball and orbital tissues
0.000 0.740 0.260
J39.2 Other diseases of pharynx
0.000 0.746 0.254
L43.9 Lichen planus, unspecified
0.250 0.749 0.000
M05-M14 Inflammatory polyarthropathies
0.250 0.750 0.000
J98.5 Diseases of mediastinum, not elsewhere classified
0.000 0.750 0.250

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.